Sector Gamma AS Sells 56,700 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sector Gamma AS decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 53.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,000 shares of the company's stock after selling 56,700 shares during the period. GE HealthCare Technologies makes up 1.3% of Sector Gamma AS's holdings, making the stock its 23rd biggest position. Sector Gamma AS's holdings in GE HealthCare Technologies were worth $3,909,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of GEHC. Lee Danner & Bass Inc. acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $80,000. Whittier Trust Co. of Nevada Inc. increased its stake in GE HealthCare Technologies by 4.4% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 77,355 shares of the company's stock worth $6,047,000 after acquiring an additional 3,240 shares during the period. Whittier Trust Co. raised its holdings in GE HealthCare Technologies by 4.4% in the 4th quarter. Whittier Trust Co. now owns 126,897 shares of the company's stock valued at $9,921,000 after acquiring an additional 5,328 shares in the last quarter. iA Global Asset Management Inc. raised its stake in GE HealthCare Technologies by 38.6% in the fourth quarter. iA Global Asset Management Inc. now owns 64,538 shares of the company's stock valued at $5,046,000 after purchasing an additional 17,987 shares in the last quarter. Finally, Teacher Retirement System of Texas boosted its position in shares of GE HealthCare Technologies by 167.8% during the 4th quarter. Teacher Retirement System of Texas now owns 112,203 shares of the company's stock worth $8,772,000 after acquiring an additional 70,300 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Remove Ads

GE HealthCare Technologies Trading Up 0.9 %

GEHC traded up $0.76 during trading on Tuesday, reaching $82.46. 3,730,072 shares of the company's stock were exchanged, compared to its average volume of 2,817,015. The firm has a fifty day moving average price of $86.91 and a two-hundred day moving average price of $85.96. The stock has a market capitalization of $37.71 billion, a PE ratio of 19.04, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on GEHC shares. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and upped their target price for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup upped their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.